Immunogenicity of rituximab in patients with severe pemphigus
Pemphigus is a life-threatening autoimmune bullous disease associated with autoantibodies to desmoglein 1 and/or 3. The anti-CD20 chimeric mouse monoclonal antibody rituximab has previously been successfully applied in more than 130 reported pemphigus patients with severe and/or refractory disease....
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 132(2009), 3 vom: 15. Sept., Seite 334-41
|
|---|
| 1. Verfasser: |
Schmidt, Enno
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Hennig, Kirsten,
Mengede, Christian,
Zillikens, Detlef,
Kromminga, Arno |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2009
|
|---|
| Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.)
|
|---|
| Schlagworte: | Journal Article
Research Support, Non-U.S. Gov't
Antibodies
Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Autoantibodies
DSG1 protein, human
DSG3 protein, human
Desmoglein 1
Desmoglein 3
mehr...
Immunologic Factors
Rituximab
4F4X42SYQ6 |
|---|